logo

For the Inventor, By the Inventor

Aalsmeer, Netherlands

Hans Pannekoek

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Stichting Sanquin Bloedvoorziening, Baxter Trading Gmbh, Gist-Brocades N.v.. Active years: 1992-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Pannekoek. Retrieved from https://idiyas.com/inventor/hans-pannekoek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 66.7



Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 271(Granted Patents)


Company Filing History:

goldMedal3 out of 28 
 
Stichting Sanquin Bloedvoorziening
 patents
silverMedal2 out of 2 
 
Baxter Trading Gmbh
 patents
bronzeMedal1 out of 236 
 
Gist-Brocades N.v.
 patents

Years Active: 1992-2013

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 8546332 - Factor VIII polypeptide having factor VIII:C activity (2013-10-01),
2. 7544660 - Factor VIII polypeptide having factor VIII:C activity (2009-06-09),
3. 6919311 - Factor VII polypeptide having factor VII:C activity (2005-07-19),
4. 6346513 - Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them (2002-02-12),
5. 6316226 - Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them (2001-11-13),
6. 5171844 - Proteins with factor VIII activity: process for their preparation using (1992-12-15),

Title: The Innovations of Hans Pannekoek

Introduction

Hans Pannekoek is a notable inventor based in Aalsmeer, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII polypeptides. With a total of 6 patents to his name, Pannekoek's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Pannekoek has developed Factor VIII polypeptides that exhibit FVIII:C activity. These polypeptides contain modifications in the A3, C1, and C2 domains of the light chain of Factor VIII. They are characterized by their binding affinity to low-density lipoprotein receptor protein, along with methods for producing these innovative polypeptides.

Career Highlights

Throughout his career, Hans Pannekoek has worked with prominent organizations such as Stichting Sanquin Bloedvoorziening and Baxter Trading GmbH. His expertise in biotechnology has allowed him to contribute to advancements in therapeutic proteins and their applications in treating hemophilia.

Collaborations

Pannekoek has collaborated with esteemed colleagues, including Martinus Philippus Verbeet and Petrus Johannes Lenting. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Hans Pannekoek's innovative work in biotechnology, particularly in the development of Factor VIII polypeptides, showcases his dedication to advancing medical science. His contributions continue to influence the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…